Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 262 entries
Sorted by: Best Match Show Resources per page
Corrigendum for Guenette L, Breton MC, Guillaumie L, Lauzier S, Gregoire JP, Moisan J. Psychosocial factors associated with adherence to non-insulin antidiabetes treatments. J Diabetes Complications 2016; 30:335-42.

Journal of diabetes and its complications

[No authors listed]
PMID: 28784268
J Diabetes Complications. 2017 Sep;31(9):1475. doi: 10.1016/j.jdiacomp.2017.07.004.

No abstract available.

Cite
Corrigendum for Guenette L, Breton MC, Guillaumie L, Lauzier S, Gregoire JP, Moisan J. Psychosocial factors associated with adherence to non-insulin antidiabetes treatments. J Diabetes Complications 2016; 30:335-42. J Diabetes Complications. 2017;31(9):1475doi: 10.1016/j.jdiacomp.2017.07.004.
(2017). Corrigendum for Guenette L, Breton MC, Guillaumie L, Lauzier S, Gregoire JP, Moisan J. Psychosocial factors associated with adherence to non-insulin antidiabetes treatments. J Diabetes Complications 2016; 30:335-42. Journal of diabetes and its complications, 31(9), 1475. https://doi.org/10.1016/j.jdiacomp.2017.07.004
"Corrigendum for Guenette L, Breton MC, Guillaumie L, Lauzier S, Gregoire JP, Moisan J. Psychosocial factors associated with adherence to non-insulin antidiabetes treatments. J Diabetes Complications 2016; 30:335-42." Journal of diabetes and its complications vol. 31,9 (2017): 1475. doi: https://doi.org/10.1016/j.jdiacomp.2017.07.004
Corrigendum for Guenette L, Breton MC, Guillaumie L, Lauzier S, Gregoire JP, Moisan J. Psychosocial factors associated with adherence to non-insulin antidiabetes treatments. J Diabetes Complications 2016; 30:335-42. J Diabetes Complications. 2017 Sep;31(9):1475. doi: 10.1016/j.jdiacomp.2017.07.004. PMID: 28784268.
Copy Download .nbib Format: NLM
Corrigendum to Intensive glycemic control in younger and older U.S. adults with type 2 diabetes [JDC 31 (2017) 1299-1304].

Journal of diabetes and its complications

Casagrande SS, Cowie CC, Fradkin JE.
PMID: 30954147
J Diabetes Complications. 2019 May;33(5):406. doi: 10.1016/j.jdiacomp.2019.03.004.

No abstract available.

Cite
Casagrande SS, Cowie CC, Fradkin JE. Corrigendum to Intensive glycemic control in younger and older U.S. adults with type 2 diabetes [JDC 31 (2017) 1299-1304]. J Diabetes Complications. 2019;33(5):406doi: 10.1016/j.jdiacomp.2019.03.004.
Casagrande, S. S., Cowie, C. C., & Fradkin, J. E. (2019). Corrigendum to Intensive glycemic control in younger and older U.S. adults with type 2 diabetes [JDC 31 (2017) 1299-1304]. Journal of diabetes and its complications, 33(5), 406. https://doi.org/10.1016/j.jdiacomp.2019.03.004
Casagrande, Sarah S, et al. "Corrigendum to Intensive glycemic control in younger and older U.S. adults with type 2 diabetes [JDC 31 (2017) 1299-1304]." Journal of diabetes and its complications vol. 33,5 (2019): 406. doi: https://doi.org/10.1016/j.jdiacomp.2019.03.004
Casagrande SS, Cowie CC, Fradkin JE. Corrigendum to Intensive glycemic control in younger and older U.S. adults with type 2 diabetes [JDC 31 (2017) 1299-1304]. J Diabetes Complications. 2019 May;33(5):406. doi: 10.1016/j.jdiacomp.2019.03.004. PMID: 30954147.
Copy Download .nbib Format: NLM
A new look at brittle diabetes.

Journal of diabetes and its complications

Hirsch IB, Gaudiani LM.
PMID: 32620472
J Diabetes Complications. 2021 Jan;35(1):107646. doi: 10.1016/j.jdiacomp.2020.107646. Epub 2020 Jun 02.

"Brittle diabetes" was first used to describe a life "disrupted by episodes of hypoglycemia or hyperglycemia." Early descriptions focused on small case reports of mostly young women with psycho-social instability, recurrent diabetic ketoacidosis, poor patient compliance or maladaptation. We...

Cite
Hirsch IB, Gaudiani LM. A new look at brittle diabetes. J Diabetes Complications. 2020;35(1):107646doi: 10.1016/j.jdiacomp.2020.107646.
Hirsch, I. B., & Gaudiani, L. M. (2021). A new look at brittle diabetes. Journal of diabetes and its complications, 35(1), 107646. https://doi.org/10.1016/j.jdiacomp.2020.107646
Hirsch, Irl B, and Gaudiani, Linda M. "A new look at brittle diabetes." Journal of diabetes and its complications vol. 35,1 (2021): 107646. doi: https://doi.org/10.1016/j.jdiacomp.2020.107646
Hirsch IB, Gaudiani LM. A new look at brittle diabetes. J Diabetes Complications. 2021 Jan;35(1):107646. doi: 10.1016/j.jdiacomp.2020.107646. Epub 2020 Jun 02. PMID: 32620472; PMCID: PMC7266594.
Copy Download .nbib Format: NLM
Reduced β-cell function and risk of retinopathy: What's the connection?.

Journal of diabetes and its complications

Utzschneider KM.
PMID: 34802901
J Diabetes Complications. 2021 Sep 10;108045. doi: 10.1016/j.jdiacomp.2021.108045. Epub 2021 Sep 10.

No abstract available.

Cite
Utzschneider KM. Reduced β-cell function and risk of retinopathy: What's the connection?. J Diabetes Complications. 2021;108045doi: 10.1016/j.jdiacomp.2021.108045.
Utzschneider, K. M. (2021). Reduced β-cell function and risk of retinopathy: What's the connection?. Journal of diabetes and its complications, 108045. https://doi.org/10.1016/j.jdiacomp.2021.108045
Utzschneider, Kristina M. "Reduced β-cell function and risk of retinopathy: What's the connection?." Journal of diabetes and its complications vol. (2021): 108045. doi: https://doi.org/10.1016/j.jdiacomp.2021.108045
Utzschneider KM. Reduced β-cell function and risk of retinopathy: What's the connection?. J Diabetes Complications. 2021 Sep 10;108045. doi: 10.1016/j.jdiacomp.2021.108045. Epub 2021 Sep 10. PMID: 34802901.
Copy Download .nbib Format: NLM
Changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus.

Journal of diabetes and its complications

Resl M, Vila G, Heinzl M, Luger A, Neuhold S, Prager R, Wurm R, Hülsmann M, Clodi M.
PMID: 34294516
J Diabetes Complications. 2021 Sep;35(9):107990. doi: 10.1016/j.jdiacomp.2021.107990. Epub 2021 Jun 26.

BACKGROUND: Based on the complex pathophysiology of type 2 diabetes and atherosclerosis we hypothesized a dynamic change in prognostic value of cardiovascular biomarkers over time.METHODS: In this prospective study 746 patients with type 2 diabetes mellitus, being followed up...

Cite
Resl M, Vila G, Heinzl M, et al. Changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus. J Diabetes Complications. 2021;35(9):107990doi: 10.1016/j.jdiacomp.2021.107990.
Resl, M., Vila, G., Heinzl, M., Luger, A., Neuhold, S., Prager, R., Wurm, R., Hülsmann, M., & Clodi, M. (2021). Changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus. Journal of diabetes and its complications, 35(9), 107990. https://doi.org/10.1016/j.jdiacomp.2021.107990
Resl, M, et al. "Changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus." Journal of diabetes and its complications vol. 35,9 (2021): 107990. doi: https://doi.org/10.1016/j.jdiacomp.2021.107990
Resl M, Vila G, Heinzl M, Luger A, Neuhold S, Prager R, Wurm R, Hülsmann M, Clodi M. Changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus. J Diabetes Complications. 2021 Sep;35(9):107990. doi: 10.1016/j.jdiacomp.2021.107990. Epub 2021 Jun 26. PMID: 34294516.
Copy Download .nbib Format: NLM
Reduced β-cell function and risk of retinopathy: What's the connection?.

Journal of diabetes and its complications

Utzschneider KM.
PMID: 34802901
J Diabetes Complications. 2022 Jan;36(1):108045. doi: 10.1016/j.jdiacomp.2021.108045. Epub 2021 Sep 10.

No abstract available.

Cite
Utzschneider KM. Reduced β-cell function and risk of retinopathy: What's the connection?. J Diabetes Complications. 2021;36(1):108045doi: 10.1016/j.jdiacomp.2021.108045.
Utzschneider, K. M. (2022). Reduced β-cell function and risk of retinopathy: What's the connection?. Journal of diabetes and its complications, 36(1), 108045. https://doi.org/10.1016/j.jdiacomp.2021.108045
Utzschneider, Kristina M. "Reduced β-cell function and risk of retinopathy: What's the connection?." Journal of diabetes and its complications vol. 36,1 (2022): 108045. doi: https://doi.org/10.1016/j.jdiacomp.2021.108045
Utzschneider KM. Reduced β-cell function and risk of retinopathy: What's the connection?. J Diabetes Complications. 2022 Jan;36(1):108045. doi: 10.1016/j.jdiacomp.2021.108045. Epub 2021 Sep 10. PMID: 34802901.
Copy Download .nbib Format: NLM
High serum copeptin may be a marker of an increased carotid intima-media thickness in asymptomatic patients with type 1 diabetes.

Journal of diabetes and its complications

Nattero-Chávez L, Martínez-García MÁ, Redondo López S, Fernández-Durán E, Dorado Avendaño B, Escobar-Morreale HF, Luque-Ramírez M.
PMID: 34823978
J Diabetes Complications. 2022 Jan;36(1):108085. doi: 10.1016/j.jdiacomp.2021.108085. Epub 2021 Nov 11.

We aimed to study the association of copeptin with carotid intima-media thickness in 60 patients with type 1 diabetes (T1DM-patients). Our results suggest that copeptin might improve the stratification of cardiovascular risk in T1DM-patients. Further research is needed to...

Cite
Nattero-Chávez L, Martínez-García MÁ, Redondo López S, et al. High serum copeptin may be a marker of an increased carotid intima-media thickness in asymptomatic patients with type 1 diabetes. J Diabetes Complications. 2021;36(1):108085doi: 10.1016/j.jdiacomp.2021.108085.
Nattero-Chávez, L., Martínez-García, M. �. �., Redondo López, S., Fernández-Durán, E., Dorado Avendaño, B., Escobar-Morreale, H. F., & Luque-Ramírez, M. (2022). High serum copeptin may be a marker of an increased carotid intima-media thickness in asymptomatic patients with type 1 diabetes. Journal of diabetes and its complications, 36(1), 108085. https://doi.org/10.1016/j.jdiacomp.2021.108085
Nattero-Chávez, Lía, et al. "High serum copeptin may be a marker of an increased carotid intima-media thickness in asymptomatic patients with type 1 diabetes." Journal of diabetes and its complications vol. 36,1 (2022): 108085. doi: https://doi.org/10.1016/j.jdiacomp.2021.108085
Nattero-Chávez L, Martínez-García MÁ, Redondo López S, Fernández-Durán E, Dorado Avendaño B, Escobar-Morreale HF, Luque-Ramírez M. High serum copeptin may be a marker of an increased carotid intima-media thickness in asymptomatic patients with type 1 diabetes. J Diabetes Complications. 2022 Jan;36(1):108085. doi: 10.1016/j.jdiacomp.2021.108085. Epub 2021 Nov 11. PMID: 34823978.
Copy Download .nbib Format: NLM
Diastolic dysfunction and impaired cardiac output reserve in dysmetabolic nonhuman primate with proteinuria.

Journal of diabetes and its complications

Wikstrom J, Liu Y, Whatling C, Gan LM, Konings P, Mao B, Zhang C, Ji Y, Xiao YF, Wang Y.
PMID: 33612386
J Diabetes Complications. 2021 Apr;35(4):107881. doi: 10.1016/j.jdiacomp.2021.107881. Epub 2021 Feb 05.

BACKGROUND: Cardiorenal complications are common in patients with dysmetabolism and diabetes. The present study aimed to examine if a nonhuman primate (NHP) model with spontaneously developed metabolic disorder and diabetes develops similar complications to humans, such as proteinuria and...

Cite
Wikstrom J, Liu Y, Whatling C, et al. Diastolic dysfunction and impaired cardiac output reserve in dysmetabolic nonhuman primate with proteinuria. J Diabetes Complications. 2021;35(4):107881doi: 10.1016/j.jdiacomp.2021.107881.
Wikstrom, J., Liu, Y., Whatling, C., Gan, L. M., Konings, P., Mao, B., Zhang, C., Ji, Y., Xiao, Y. F., & Wang, Y. (2021). Diastolic dysfunction and impaired cardiac output reserve in dysmetabolic nonhuman primate with proteinuria. Journal of diabetes and its complications, 35(4), 107881. https://doi.org/10.1016/j.jdiacomp.2021.107881
Wikstrom, Johannes, et al. "Diastolic dysfunction and impaired cardiac output reserve in dysmetabolic nonhuman primate with proteinuria." Journal of diabetes and its complications vol. 35,4 (2021): 107881. doi: https://doi.org/10.1016/j.jdiacomp.2021.107881
Wikstrom J, Liu Y, Whatling C, Gan LM, Konings P, Mao B, Zhang C, Ji Y, Xiao YF, Wang Y. Diastolic dysfunction and impaired cardiac output reserve in dysmetabolic nonhuman primate with proteinuria. J Diabetes Complications. 2021 Apr;35(4):107881. doi: 10.1016/j.jdiacomp.2021.107881. Epub 2021 Feb 05. PMID: 33612386.
Copy Download .nbib Format: NLM
Evidence of dysregulated iron homeostasis in newly diagnosed diabetics, but not in pre-diabetics.

Journal of diabetes and its complications

Venkatesan P, Varghese J, Arthi TS, James JV, Anura A, Prasad J, Jacob M.
PMID: 34217587
J Diabetes Complications. 2021 Sep;35(9):107977. doi: 10.1016/j.jdiacomp.2021.107977. Epub 2021 Jun 19.

AIM: Diabetes mellitus has been reported to be associated with increased serum levels of ferritin. The basis of this association is unclear. It is also not precisely known whether other iron-related parameters, including hepcidin (the central regulator of systemic...

Cite
Venkatesan P, Varghese J, Arthi TS, et al. Evidence of dysregulated iron homeostasis in newly diagnosed diabetics, but not in pre-diabetics. J Diabetes Complications. 2021;35(9):107977doi: 10.1016/j.jdiacomp.2021.107977.
Venkatesan, P., Varghese, J., Arthi, T. S., James, J. V., Anura, A., Prasad, J., & Jacob, M. (2021). Evidence of dysregulated iron homeostasis in newly diagnosed diabetics, but not in pre-diabetics. Journal of diabetes and its complications, 35(9), 107977. https://doi.org/10.1016/j.jdiacomp.2021.107977
Venkatesan, Padmanaban, et al. "Evidence of dysregulated iron homeostasis in newly diagnosed diabetics, but not in pre-diabetics." Journal of diabetes and its complications vol. 35,9 (2021): 107977. doi: https://doi.org/10.1016/j.jdiacomp.2021.107977
Venkatesan P, Varghese J, Arthi TS, James JV, Anura A, Prasad J, Jacob M. Evidence of dysregulated iron homeostasis in newly diagnosed diabetics, but not in pre-diabetics. J Diabetes Complications. 2021 Sep;35(9):107977. doi: 10.1016/j.jdiacomp.2021.107977. Epub 2021 Jun 19. PMID: 34217587.
Copy Download .nbib Format: NLM
Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis.

Journal of diabetes and its complications

Sagara M, Iijima T, Kase M, Kato K, Sakurai S, Tomaru T, Jojima T, Usui I, Aso Y.
PMID: 33602617
J Diabetes Complications. 2021 May;35(5):107885. doi: 10.1016/j.jdiacomp.2021.107885. Epub 2021 Feb 06.

AIM: To investigate the relationship in people with type 2 diabetes between serum soluble dipeptidyl peptidase-4 (sDDP-4) and degree of liver fibrosis assessed as the liver stiffness measurement (LSM) and FAST (FibroScan-AST) score, both of which were measured by...

Cite
Sagara M, Iijima T, Kase M, et al. Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis. J Diabetes Complications. 2021;35(5):107885doi: 10.1016/j.jdiacomp.2021.107885.
Sagara, M., Iijima, T., Kase, M., Kato, K., Sakurai, S., Tomaru, T., Jojima, T., Usui, I., & Aso, Y. (2021). Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis. Journal of diabetes and its complications, 35(5), 107885. https://doi.org/10.1016/j.jdiacomp.2021.107885
Sagara, Masaaki, et al. "Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis." Journal of diabetes and its complications vol. 35,5 (2021): 107885. doi: https://doi.org/10.1016/j.jdiacomp.2021.107885
Sagara M, Iijima T, Kase M, Kato K, Sakurai S, Tomaru T, Jojima T, Usui I, Aso Y. Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis. J Diabetes Complications. 2021 May;35(5):107885. doi: 10.1016/j.jdiacomp.2021.107885. Epub 2021 Feb 06. PMID: 33602617.
Copy Download .nbib Format: NLM
Glucagon use by U.S. adults with type 1 and type 2 diabetes.

Journal of diabetes and its complications

Kahn PA, Liu S, McCoy R, Gabbay RA, Lipska K.
PMID: 33593689
J Diabetes Complications. 2021 May;35(5):107882. doi: 10.1016/j.jdiacomp.2021.107882. Epub 2021 Feb 06.

The American Diabetes Association recommends that all patients at risk for hypoglycemia be prescribed glucagon. Despite this recommendation, there is evidence that prescription rates are lower than expected for patients with type 1 and type 2 diabetes. This study...

Cite
Kahn PA, Liu S, McCoy R, et al. Glucagon use by U.S. adults with type 1 and type 2 diabetes. J Diabetes Complications. 2021;35(5):107882doi: 10.1016/j.jdiacomp.2021.107882.
Kahn, P. A., Liu, S., McCoy, R., Gabbay, R. A., & Lipska, K. (2021). Glucagon use by U.S. adults with type 1 and type 2 diabetes. Journal of diabetes and its complications, 35(5), 107882. https://doi.org/10.1016/j.jdiacomp.2021.107882
Kahn, Peter A, et al. "Glucagon use by U.S. adults with type 1 and type 2 diabetes." Journal of diabetes and its complications vol. 35,5 (2021): 107882. doi: https://doi.org/10.1016/j.jdiacomp.2021.107882
Kahn PA, Liu S, McCoy R, Gabbay RA, Lipska K. Glucagon use by U.S. adults with type 1 and type 2 diabetes. J Diabetes Complications. 2021 May;35(5):107882. doi: 10.1016/j.jdiacomp.2021.107882. Epub 2021 Feb 06. PMID: 33593689; PMCID: PMC8054027.
Copy Download .nbib Format: NLM
Differential effects of sex on adaptive responses of skeletal muscle vasodilation to exercise training in type 2 diabetes.

Journal of diabetes and its complications

Green S, Kiely C, O'Connor E, Gildea N, O'Shea D, Egaña M.
PMID: 34887186
J Diabetes Complications. 2021 Nov 29;108098. doi: 10.1016/j.jdiacomp.2021.108098. Epub 2021 Nov 29.

AIMS: We tested the hypotheses that exercise training improves the peak and dynamic responses of leg vascular conductance (LVC) in males and females with type 2 diabetes (T2DM).METHODS: Forty-one males and females with T2DM were assigned to two training...

Cite
Green S, Kiely C, O'Connor E, et al. Differential effects of sex on adaptive responses of skeletal muscle vasodilation to exercise training in type 2 diabetes. J Diabetes Complications. 2021;108098doi: 10.1016/j.jdiacomp.2021.108098.
Green, S., Kiely, C., O'Connor, E., Gildea, N., O'Shea, D., & Egaña, M. (2021). Differential effects of sex on adaptive responses of skeletal muscle vasodilation to exercise training in type 2 diabetes. Journal of diabetes and its complications, 108098. https://doi.org/10.1016/j.jdiacomp.2021.108098
Green, Simon, et al. "Differential effects of sex on adaptive responses of skeletal muscle vasodilation to exercise training in type 2 diabetes." Journal of diabetes and its complications vol. (2021): 108098. doi: https://doi.org/10.1016/j.jdiacomp.2021.108098
Green S, Kiely C, O'Connor E, Gildea N, O'Shea D, Egaña M. Differential effects of sex on adaptive responses of skeletal muscle vasodilation to exercise training in type 2 diabetes. J Diabetes Complications. 2021 Nov 29;108098. doi: 10.1016/j.jdiacomp.2021.108098. Epub 2021 Nov 29. PMID: 34887186.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 262 entries